Bone Biologics Corporation (BBLG) Balance Sheet
BBLG balance sheet, 2025
December 31, 2025 · U.S. dollars$5.8M assets = $418,587 liabilities + $5.4M equity
Both columns are drawn to the same scale: what BBLG owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BBLG financial health
Descriptive bands, not a rating. Fiscal 2025.
BBLG balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $973,0852016 | $5.8M2025 | +21.9%/yr | |
| Total liabilities | $9.6M2016 | $418,5872025 | −29.4%/yr | |
| Shareholders’ equity | −$8.4M2016 | $5.4M2025 | — | |
| Cash & short-term investments | $620,3752016 | $5.3M2025 | +27.0%/yr | |
| Total debt | $8.8M2016 | −$783,6742023 | — | |
| Net cash (debt) | −$8.1M2016 | $3.8M2023 | +$12.0M | |
| Working capital | −$800,9182016 | $5.4M2025 | +$6.2M | |
| Book value per share | $2.302024 | $4.582025 | +99.3%/yr | |
| Debt / equity | 0.132022 | −0.272023 | −0.40 | |
| Shares outstanding | 1.5M2024 | 1.2M2025 | −22.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BBLG assets
BBLG liabilities and equity
BBLG debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BBLG balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $5.3M | $3.3M | $3.0M | $7.5M | $6.7M | $0 | $24,145 | $955,374 | $690,279 | $620,375 |
| Cash & equivalents | $5.3M | $3.3M | $3.0M | $7.5M | $6.7M | $0 | $24,145 | $955,374 | $690,279 | $620,375 |
| Short-term investments | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Receivables | $9,895 | $0 | $328,844 | $579,910 | $0 | $0 | $0 | $0 | $0 | $271,945 |
| Inventory | $0 | $0 | −$579,910 | −$579,910 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $451,918 | $536,238 | $962,260 | $956,925 | $0 | $0 | $6,682 | $85,288 | $105,234 | $0 |
| Total current assets | $5.8M | $3.9M | $3.7M | $8.5M | $6.7M | $0 | $30,827 | $1.0M | $795,513 | $700,898 |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $50 | $146 | $242 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $271,945 |
| Total assets | $5.8M | $3.9M | $3.7M | $8.5M | $6.7M | $0 | $30,827 | $1.0M | $795,659 | $973,085 |
| Liabilities | ||||||||||
| Accounts payable | $417,884 | $373,042 | $360,662 | $888 | $99,909 | $465,396 | $42,879 | $125,203 | $216,903 | $226,516 |
| Short-term debt | — | — | −$783,674 | $783,674 | — | $11.7M | — | $9.0M | $0 | $1.2M |
| Deferred revenue | — | — | $783,675 | $783,675 | — | — | — | — | — | $75,300 |
| Total current liabilities | $418,587 | $377,712 | $831,402 | $2.5M | $99,909 | $13.7M | $578,447 | $9.6M | $961,795 | $1.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $11.3M | $0 | $0 | $0 |
| Lease obligations | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $888 | $888 | $99,909 | $12.2M | $0 | $0 | $8.2M | $7.6M |
| Total liabilities | $418,587 | $377,712 | $831,402 | $2.5M | $99,909 | $13.7M | $11.9M | $9.6M | $9.2M | $9.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $1,795 | $2,953 | $534 | $15,300 | $10,350 | $30,682 | $30,682 | $26,449 | $43,280 | $38,829 |
| Retained earnings (deficit) | −$88.1M | −$85.0M | −$80.9M | −$72.0M | −$70.5M | −$68.9M | −$67.0M | −$63.6M | −$59.2M | −$52.1M |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | $0 | −$357 | $1.8M |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $5.4M | $3.5M | $2.9M | $5.9M | $6.6M | −$13.7M | −$11.9M | −$8.6M | −$8.4M | −$8.4M |
| Key figures | ||||||||||
| Total debt | — | — | −$783,674 | $783,674 | — | $11.7M | $11.3M | $9.0M | $8.2M | $8.8M |
| Net cash (debt) | — | — | $3.8M | $6.8M | — | −$11.7M | −$11.3M | −$8.0M | −$7.5M | −$8.1M |
| Working capital | $5.4M | $3.5M | $2.9M | $5.9M | $6.6M | −$13.7M | −$547,620 | −$8.6M | −$166,282 | −$800,918 |
| Tangible book value | $5.4M | $3.5M | $2.9M | $5.9M | $6.6M | −$13.7M | −$11.9M | −$8.6M | −$8.4M | −$8.4M |
| Book value per share | $4.58 | $2.30 | — | — | — | — | — | — | — | — |
| Shares outstanding | 1.2M | 1.5M | — | — | — | — | — | — | — | — |
| Current ratio | 13.85 | 10.22 | 4.50 | 3.33 | 66.81 | 0.00 | 0.05 | 0.11 | 0.83 | 0.47 |
| Quick ratio | 12.77 | 8.80 | 4.04 | 3.19 | 66.81 | 0.00 | 0.04 | 0.10 | 0.72 | 0.59 |
| Debt / equity | — | — | −0.27 | 0.13 | — | — | — | — | — | — |
| Equity / assets | 92.8% | 90.2% | 77.8% | 70.0% | 98.5% | — | −38,497.5% | −826.2% | −1,055.2% | −859.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $4.0M | $4.5M | $5.3M | $6.0M | $6.6M | $2.7M | $3.3M | $3.6M | $2.3M | $3.2M | $3.0M | $4.5M |
| Cash & equivalents | $4.0M | $4.5M | $5.3M | $6.0M | $6.6M | $2.7M | $3.3M | $3.6M | $2.3M | $3.2M | $3.0M | $4.5M |
| Receivables | $6,986 | $7,809 | $9,895 | $0 | $0 | $0 | $0 | $0 | $0 | $328,844 | $328,844 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$328,844 | −$328,844 | −$579,910 |
| Other current assets | $397,902 | $441,456 | $451,918 | $301,715 | $361,748 | $415,505 | $536,238 | $499,392 | $861,396 | $611,940 | $711,194 | $1.1M |
| Total current assets | $4.4M | $5.0M | $5.8M | $6.4M | $7.0M | $3.2M | $3.9M | $4.1M | $3.2M | $3.8M | $3.7M | $5.0M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $4.4M | $5.0M | $5.8M | $6.4M | $7.0M | $3.2M | $3.9M | $4.1M | $3.2M | $3.8M | $3.7M | $5.0M |
| Liabilities | ||||||||||||
| Accounts payable | $511,472 | $308,948 | $417,884 | $333,081 | $403,729 | $247,843 | $373,042 | $190,057 | $231,872 | $146,186 | $360,662 | $1.1M |
| Deferred revenue | — | — | — | — | — | — | — | — | $44,980 | — | — | $783,675 |
| Total current liabilities | $512,018 | $309,386 | $418,587 | $334,282 | $406,142 | $251,158 | $377,712 | $273,402 | $284,507 | $164,626 | $831,402 | $1.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $888,461 |
| Total liabilities | $512,018 | $309,386 | $418,587 | $334,282 | $406,142 | $251,158 | $377,712 | $273,402 | $284,507 | $164,626 | $831,402 | $1.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1,810 | $1,795 | $1,795 | $1,795 | $1,685 | $3,270 | $2,953 | $2,096 | $1,315 | $1,016 | $534 | $3,135 |
| Retained earnings (deficit) | −$89.7M | −$88.9M | −$88.1M | −$87.4M | −$86.8M | −$86.0M | −$85.0M | −$83.5M | −$82.6M | −$81.8M | −$80.9M | −$79.4M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | — | — | $0 |
| Total shareholders' equity | $3.9M | $4.7M | $5.4M | $6.0M | $6.6M | $2.9M | $3.5M | $3.8M | $2.9M | $3.7M | $2.9M | $3.8M |
| Key figures | ||||||||||||
| Working capital | $3.9M | $4.7M | $5.4M | $6.0M | $6.6M | $2.9M | $3.5M | $3.8M | $2.9M | $3.7M | $2.9M | $3.8M |
| Tangible book value | $3.9M | $4.7M | $5.4M | $6.0M | $6.6M | $2.9M | $3.5M | $3.8M | $2.9M | $3.7M | $2.9M | $3.8M |
| Book value per share | $2.18 | $2.60 | $4.58 | $3.35 | $11.83 | $0.91 | $1.18 | $2.16 | $2.49 | $5.56 | — | — |
| Shares outstanding | 1.8M | 1.8M | 1.2M | 1.8M | 558K | 3.2M | 3.0M | 1.8M | 1.2M | 661K | — | — |
| Current ratio | 8.67 | 16.09 | 13.85 | 19.00 | 17.24 | 12.59 | 10.22 | 14.87 | 11.22 | 23.32 | 4.50 | 4.21 |
| Quick ratio | 7.89 | 14.67 | 12.77 | 18.10 | 16.35 | 10.94 | 8.80 | 13.04 | 8.20 | 21.60 | 4.04 | 3.76 |
| Equity / assets | 88.5% | 93.8% | 92.8% | 94.7% | 94.2% | 92.1% | 90.2% | 93.3% | 91.1% | 95.7% | 77.8% | 76.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 2, 2026); data from EODHD.
BBLG financial position
At the end of fiscal 2025 (December 31, 2025), Bone Biologics had total assets of $5.8 million (up 50.1% from a year earlier), total liabilities of $0.4 million and shareholders' equity of $5.4 million. Its current ratio was 13.85. In the latest quarter (ended June 30, 2026) total assets were $4.4 million and equity $3.9 million.
Related: BBLG income statement, BBLG cash flow statement, BBLG key metrics. See the BBLG stock overview for the latest quote and news.
BBLG balance sheet FAQ
What are Bone Biologics's total assets?
Bone Biologics reported total assets of $5.8 million at the end of fiscal 2025 (December 31, 2025), compared with $3.9 million a year earlier.
How much cash does Bone Biologics have?
Bone Biologics held $5.3 million in cash and short-term investments at the end of fiscal 2025.
What is Bone Biologics's book value?
Bone Biologics's shareholders' equity (book value) was $5.4 million at the end of fiscal 2025, or $4.58 per share.
What is Bone Biologics's current ratio?
Bone Biologics had current assets of $5.8 million and current liabilities of $0.4 million, a current ratio of 13.85 (it can cover its short-term obligations).